GlassScriptPhysician profile
Ginny L Guyton
NPI 1619957982
$1,325.69
in general payments reported to CMS, 2019-2025
17 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $255 · 2021: $252 · 2022: $140 · 2023: $143 · 2024: $176 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $258.36 | 2019-2022 | |
| Glaxosmithkline, LLC. | $216.35 | 2019-2025 | Rotarix, Bexsero, Penmenvy |
| Pfizer INC. | $214.34 | 2019-2025 | |
| Cranial Technologies, INC | $130.63 | 2019-2024 | Doc Band |
| Merck Sharp & Dohme LLC | $124.31 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Sanofi Pasteur INC. | $100.42 | 2021-2025 | |
| Kaleo, INC. | $52.95 | 2019-2023 | Auvi-Q |
| Seqirus USA INC | $37.12 | 2025 | Flucelvax |
| Phadia US INC. | $27.30 | 2020 | |
| Neos Therapeutics, LP | $25.88 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $25.53 | 2024 | Flumist Quadrivalent |
| Boston Scientific Corporation | $24.09 | 2020 | |
| Verrica Pharmaceuticals INC. | $23.84 | 2024 | Ycanth |
| Alk-Abello, INC | $18.51 | 2025 | Neffy |
| Teva Pharmaceuticals USA, INC. | $17.56 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $14.42 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginny Guyton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.